NCT03572192 Tissue Collection Framework To Improve Outcomes In Solid Tumours Status RECRUITING Phase N/A
NCT03415100 Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours Status UNKNOWN Phase PHASE1
NCT03333824 Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT03315091 Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT03266159 A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors Status WITHDRAWN Phase PHASE2
NCT03150056 Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT02923947 Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment Status COMPLETED Phase PHASE1
NCT02687386 A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR Status TERMINATED Phase PHASE1
NCT02492477 TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients Status TERMINATED Phase PHASE1
NCT02407509 Phase I Trial of VS-6766 Alone and in Combination With Everolimus Status COMPLETED Phase PHASE1
NCT02343718 Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours Status COMPLETED Phase PHASE1
NCT02264418 Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT02263950 A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours Status UNKNOWN Phase PHASE1/PHASE2
NCT02215850 Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT02161770 Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment Status COMPLETED Phase PHASE1
NCT02093728 To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02093351 To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer Status COMPLETED Phase PHASE1
NCT02063204 To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects Status COMPLETED Phase PHASE1